InvesTrust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5M Sell
17,721
-505
-3% -$118K 1.73% 19
2026
Q1
$4.46M Sell
18,226
-139
-0.8% -$32.4K 1.87% 17
2025
Q4
$3.8M Sell
18,365
-1,886
-9% -$373K 1.47% 18
2025
Q3
$3.75M Sell
20,251
-81
-0.4% -$13.9K 1.38% 23
2025
Q2
$3.11M Sell
20,332
-24,459
-55% -$3.76M 1.2% 28
2025
Q1
$7.43M Buy
44,791
+689
+2% +$108K 2.03% 17
2024
Q4
$6.35M Buy
+44,102
New +$6.83M 1.77% 25

Other funds holding JNJ

InvesTrust's JNJ Position: Q2 2026 in Review

InvesTrust reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, selling an estimated $118K and leaving 17,721 shares worth $4.5M. The position accounts for 1.73% of the portfolio, ranked #19.

InvesTrust first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.43M in Q1 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • InvesTrust held 17,721 shares of Johnson & Johnson worth $4.5M as of Q2 2026.
  • InvesTrust sold 505 Johnson & Johnson shares in Q2 2026, an estimated $118K.
  • Johnson & Johnson made up 1.73% of InvesTrust's portfolio in Q2 2026, its #19 holding.
  • InvesTrust first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • InvesTrust's Johnson & Johnson position peaked at $7.43M in Q1 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on InvesTrust's 13F filing for Q2 2026, filed 14 Jul 2026.